Amylyx Pharmaceuticals, Inc. - COM (AMLX)

Historical Portfolio Holders from Q1 2022 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
43.4M
Holdings value Q3 2024
$141M
Value change Q3 2024
+$5.13M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
107
Number of buys Q3 2024
52
Number of sells Q3 2024
-65
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 43.4M $141M +$5.13M $3.24 109
2024 Q2 43.6M $82.9M -$16.9M $1.90 116
2024 Q1 49.5M $141M -$235M $2.84 145
2023 Q4 60.3M $887M -$11.9M $14.72 183
2023 Q3 58.9M $1.08B +$84.1M $18.31 172
2023 Q2 54.5M $1.18B +$56.2M $21.57 155
2023 Q1 51.4M $1.51B +$73.7M $29.34 150
2022 Q4 48.5M $1.79B +$421M $36.95 132
2022 Q3 36.8M $1.04B +$315M $28.15 95
2022 Q2 26.6M $513M +$65.3M $19.26 78
2022 Q1 23.4M $300M +$300M $12.85 72